warnings
Warnings - For external use only. - Avoid contact with eyes.
Lidozall Plus
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- Brand name
- Lidozall Plus
- Generic name
- LIDOCAINE HYDROCHLORIDE
- Manufacturer
- V2 Pharma LLC
- Product type
- HUMAN OTC DRUG
- SPL set ID
- ba3cbb15-f4ed-443e-af43-a758481acb0b
- SPL ID
- 436cf516-6a9d-d59c-e063-6394a90a65e3
- Version
- 8
- Effective date
- 2025-11-12
- Source export date
- 2026-09-28
- Source partition
- 2
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0002-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-09-28/f7d2b6e3f8600cd856280ab55a9c6fa54a642647191d164f9d1110e89f3f4097/drug-label-0002-of-0014.json.zip
- Source manifest SHA-256
- cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
- Import run
- 20260929T050834Z
- Imported at
- 2026-09-29 05:14:45
| Harmonized routes |
|---|
| TOPICAL |
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| application number | M017 | openfda.application_number | |
| brand name | Lidozall Plus | openfda.brand_name | |
| generic name | LIDOCAINE HYDROCHLORIDE | openfda.generic_name | |
| manufacturer name | V2 Pharma LLC | openfda.manufacturer_name | |
| ndc | package | 72835-114-15 | openfda.package_ndc |
| ndc | product | 72835-114 | openfda.product_ndc |
| ndc11 | package | 72835011415 | derived:openfda.package_ndc |
| rxcui | 1010895 | openfda.rxcui | |
| spl id | 436cf516-6a9d-d59c-e063-6394a90a65e3 | id | |
| spl set id | ba3cbb15-f4ed-443e-af43-a758481acb0b | set_id | |
| unii | V13007Z41A | openfda.unii |
Warnings cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.